Patient Guide: A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 50 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT05743881
Status: ACTIVE_NOT_RECRUITING
Condition: Respiratory Syncytial Virus, Human Metapneumovirus
Phase: PHASE1

Find a Study Location Near You

This study is available at 50 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Los Angeles, California
  • • Los Angeles, California
  • • Englewood, Colorado
  • • And 47 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months - Join Clinical Trial NCTNCT05743881

How to Join This Clinical Trial - NCTNCT05743881

Learn how to participate in this PHASE1 trial studying an investigational therapy for Respiratory Syncytial Virus, Human Metapneumovirus. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Respiratory Syncytial Virus, Human Metapneumovirus. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Respiratory Syncytial Virus, Human Metapneumovirus
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05743881 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 50 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90057 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90095 - United States

Status: Contact for availability

Clinical Research Site

Englewood, Colorado 80110 - United States

Status: Contact for availability

Clinical Research Site

Washington D.C., District of Columbia 20016-4358 - United States

Status: Contact for availability

Clinical Research Site

Washington D.C., District of Columbia 20016 - United States

Status: Contact for availability

Clinical Research Site

Jacksonville, Florida 32209 - United States

Status: Contact for availability

Clinical Research Site

Orlando, Florida 32829-8070 - United States

Status: Contact for availability

Clinical Research Site

Idaho Falls, Idaho 83404 - United States

Status: Contact for availability

Clinical Research Site

Lafayette, Louisiana 70508 - United States

Status: Contact for availability

Clinical Research Site

Worcester, Massachusetts 01655-0002 - United States

Status: Contact for availability

And 40 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Respiratory Syncytial Virus, Human Metapneumovirus:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation